IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C Crit Rev Toxicol38p87-96(2008)

Proteomic analysis of cholangiocarcinoma cell line. Srisomsap C*, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J. Proteomics. 2004 Apr;4(4):1135-44.

CACNA1S mutation-associated dental anomalies: A calcium channelopathy Kantaputra P, Butali A, Eliason S, Chalkley C, Nakornchai S, Bongkochwilawan C, Kawasaki K, Kumchiang A, Ngamphiw C, Tongsima S, Cairns JRK, Olsen B, Intachai W, Ohazama A, Tucker AS, Amendt BA Oral Dis. 2024;30(3):1350-9.